Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Zammit

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Drug Safety|August 13, 2009
Comparative tolerability of newer agents for insomniaGary Zammit
Expert Opinion on Drug Metabolism & Toxicology|March 28, 2008
Zolpidem extended-release: therapy for sleep induction and sleep maintenance difficultiesGary Zammit
Expert Opinion on Pharmacotherapy|March 12, 2021
Evaluating lemborexant for the treatment of insomniaGary Zammit, Andrew Krystal
Human Psychopharmacology|April 26, 2016
The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomniaAndrew D Krystal, Gary Zammit
BMC Geriatrics|July 17, 2008
Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a referenceGary Zammit, Sherry Wang-Weigand, Xuejun Peng
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 26, 2009
Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomniaGary Zammit, Sherry Wang-Weigand, Murray Rosenthal, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 6, 2020
Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakeningPatricia Murphy, Dinesh Kumar, Gary Zammit, et al.
Sleep Medicine|November 29, 2005
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomniaMilton Erman, David Seiden, Gary Zammit, et al.
The Journal of Clinical Psychiatry|March 17, 2009
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label studyGary S Richardson, Gary Zammit, Sherry Wang-Weigand, et al.
Human Psychopharmacology|December 15, 2019
Efficacy of SM-1 in a transient insomnia modelThomas Dahl, Lan Bo Chen, Gary Zammit, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Drug Safety|August 13, 2009
Comparative tolerability of newer agents for insomniaGary Zammit
Expert Opinion on Drug Metabolism & Toxicology|March 28, 2008
Zolpidem extended-release: therapy for sleep induction and sleep maintenance difficultiesGary Zammit
Expert Opinion on Pharmacotherapy|March 12, 2021
Evaluating lemborexant for the treatment of insomniaGary Zammit, Andrew Krystal
Human Psychopharmacology|April 26, 2016
The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomniaAndrew D Krystal, Gary Zammit
BMC Geriatrics|July 17, 2008
Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a referenceGary Zammit, Sherry Wang-Weigand, Xuejun Peng
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 26, 2009
Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomniaGary Zammit, Sherry Wang-Weigand, Murray Rosenthal, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 6, 2020
Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakeningPatricia Murphy, Dinesh Kumar, Gary Zammit, et al.
Sleep Medicine|November 29, 2005
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomniaMilton Erman, David Seiden, Gary Zammit, et al.
The Journal of Clinical Psychiatry|March 17, 2009
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label studyGary S Richardson, Gary Zammit, Sherry Wang-Weigand, et al.
Human Psychopharmacology|December 15, 2019
Efficacy of SM-1 in a transient insomnia modelThomas Dahl, Lan Bo Chen, Gary Zammit, et al.
Pageof 6